Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H10O |
| Molecular Weight | 86.1323 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1CCCC1
InChI
InChIKey=XCIXKGXIYUWCLL-UHFFFAOYSA-N
InChI=1S/C5H10O/c6-5-3-1-2-4-5/h5-6H,1-4H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phthalazine PDE4 inhibitors. Part 2: the synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives. | 2001 Jan 8 |
|
| Methanobacterium congolense sp. nov., from a methanogenic fermentation of cassava peel. | 2001 Mar |
|
| An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base. | 2001 Mar 9 |
|
| Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding. | 2002 Aug 19 |
|
| Phthalazine PDE4 inhibitors. Part 3: the synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor. | 2002 Jan 7 |
|
| Effects of topical mydriatics and vasoconstrictors on prostaglandin-E2-induced aqueous flare elevation in pigmented rabbits. | 2003 Sep-Oct |
|
| Thermodynamics of the molecular and chiral recognition of cycloalkanols and camphor by modified beta-cyclodextrins possessing simple aromatic tethers. | 2004 Jan 9 |
|
| Detector for liquid chromatography based on acoustic emissions from an oscillating flame. | 2004 Sep 15 |
|
| High-pressure polymorphism of cyclopentanol (C5H10O): the structure of cyclopentanol phase-V at 1.5 GPa. | 2005 Sep |
|
| Evaluation of PDE4 inhibition for COPD. | 2006 |
|
| Chiral microemulsion electrokinetic chromatography: Effect of cosurfactant identity on enantioselectivity, methylene selectivity, resolution, and other chromatographic figures of merit. | 2006 Nov |
|
| Analysis of volatile compounds as spoilage indicators in fresh king salmon (Oncorhynchus tshawytscha) during storage using SPME-GC-MS. | 2006 Nov 1 |
|
| Stereoselective preparation of a cyclopentane-based NK1 receptor antagonist bearing an unsymmetrically substituted sec-sec ether. | 2006 Sep 15 |
|
| Diastereoselective multicomponent cyclizations of Fischer carbene complexes, lithium enolates, and allylmagnesium bromide leading to highly substituted five- and six-membered carbocycles. | 2006 Sep 18 |
|
| The changes of posterior corneal surface and high-order aberrations after refractive surgery in moderate myopia. | 2007 Sep |
|
| Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation. | 2009 |
|
| Nummular keratopathy in a patient with Hyper-IgD Syndrome. | 2009 Aug 5 |
|
| The effect of epiblepharon surgery on visual acuity and with-the-rule astigmatism in children. | 2010 Dec |
|
| Use of visual acuity to screen for significant refractive errors in adolescents: is it reliable? | 2010 Jul |
|
| Three-component coupling reactions of silyl glyoxylates, vinyl Grignard reagent, and nitroalkenes: an efficient, highly diastereoselective approach to nitrocyclopentanols. | 2010 Nov 15 |
|
| Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina. | 2010 Nov 6 |
|
| Changes in protein profiles of guinea pig sclera during development of form deprivation myopia and recovery. | 2010 Oct 27 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C016327
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
CYCLOPENTANOL
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
16133
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
DTXSID1033371
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
202-504-8
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
2821
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
7298
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
m4007
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | Merck Index | ||
|
1L43Q07TBU
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
96-41-3
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY | |||
|
49117
Created by
admin on Sat Dec 16 02:16:46 GMT 2023 , Edited by admin on Sat Dec 16 02:16:46 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
